BioStem said the acquisition will support its advancement into ‘high value’ adjacent market segments.
Innovations in medical treatments play a pivotal role in enhancing patient care. One such breakthrough technology that has shown significant promise in wound care is amniotic membrane skin substitutes ...
The two initial products ready for commercialization include a cryopreserved allograft derived from human placental tissues that is used as a wound covering in the treatment of localized tissue ...
BioTissue Holdings, Inc, a leader in harnessing the unique properties of human birth tissue to facilitate regenerative ...
Micro-cap Alliqua Biomedical ($ALQA) has amended its exclusive licensing deal with Celgene Cellular Therapeutics, a subsidiary of Celgene ($CELG), to add the right to ...
PHOENIX, Oct. 2, 2024 /PRNewswire/ -- BioLab Holdings, Inc.'s skin substitute brand, BioLab Sciences, a Phoenix-based medical manufacturer specializing in wound healing and wound care products, ...
AlloSource®, one of the nation's largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, today ...
BIOVANCE, an amniotic membrane allograft derived from a human placenta, is now available for those looking for a wound care product. Made by Alliqua Biomedical Inc., BIOVANCE is meant to reduce ...
New York, USA, July 30, 2025 (GLOBE NEWSWIRE) -- Global Amniotic Membrane Market Poised for Extraordinary Growth at a CAGR of ~7% by 2032 | DelveInsight The amniotic membrane market is experiencing ...
DUBLIN--(BUSINESS WIRE)--The "Global Amniotic Membrane Market Report by Application Product End User Countries and Company Analysis, 2024-2032" report has been added to ResearchAndMarkets.com's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results